Sophisticated Cybercrime Group Targeting Health Care Providers
The FBI and other federal agencies have issued warnings about a ransomware and data extortion group called the Daixin Team.
All articles by John Schieszer, MA
Dialysis Initiation Is Followed by Stabilization of Symptom Number, Burden
Study findings could help inform older patients who opt to start dialysis on what to expect regarding development of their symptom burden, according to investigators.
Cybercriminals Step Up Attacks on Health Care Payment Processors
Criminals are compromising user login credentials of health care payment processors to divert payments from medical practices to themselves, the FBI warns.
Cyberattacks in Health Care Are Escalating
A recent survey revealed that the health care sector is not making IT systems and third-party security top priority.
Metastasis-Directed Therapy Beneficial in Oligometastatic Prostate Cancer
Investigators reported findings from the first randomized trial to evaluate the use of metastasis-directed therapy with hormone therapy in patients with oligometastatic prostate cancer.
SABR ‘Quite Safe’ for Treating Oligometastases
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
Scoring System Differentiates Malignant and Benign Renal Masses
A validated algorithm for assessing solid renal masses could be useful in clinical practice.
How Patients Choose Small Renal Mass Treatment Characterized
Patients choosing active surveillance perceived cancer and metastasis risks to be lower compared with those opting for surgery and ablation, a study showed.
Progression Criteria Could Improve Active Surveillance for Renal Masses
Recent findings may be useful for patient counseling and in designing active surveillance research studies.
Biomarker Could Improve Management of Renal Medullary Carcinoma
Study showed that 82% of patients had elevated CA-125 levels at any point during their disease course.
- Loading...
Loading...
Next post in IKCS 2022
Loading... 
Loading...